annual operating expenses:
$438.06M-$33.94M(-7.19%)Summary
- As of today (September 16, 2025), TVTX annual total operating expenses is $438.06 million, with the most recent change of -$33.94 million (-7.19%) on December 31, 2024.
- During the last 3 years, TVTX annual operating expenses has risen by +$104.47 million (+31.32%).
- TVTX annual operating expenses is now -7.19% below its all-time high of $472.00 million, reached on December 31, 2023.
Performance
TVTX Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$111.56M+$4.64M(+4.34%)Summary
- As of today (September 16, 2025), TVTX quarterly total operating expenses is $111.56 million, with the most recent change of +$4.64 million (+4.34%) on June 30, 2025.
- Over the past year, TVTX quarterly operating expenses has increased by +$2.80 million (+2.58%).
- TVTX quarterly operating expenses is now -13.88% below its all-time high of $129.54 million, reached on June 30, 2023.
Performance
TVTX quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
TVTX Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.2% | +2.6% |
| 3 y3 years | +31.3% | +6.7% |
| 5 y5 years | +75.6% | +84.5% |
TVTX Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.2% | +31.3% | -13.9% | +7.9% |
| 5 y | 5-year | -7.2% | +78.7% | -13.9% | +91.4% |
| alltime | all time | -7.2% | >+9999.0% | -13.9% | >+9999.0% |
TVTX Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $111.56M(+4.3%) |
| Mar 2025 | - | $106.92M(-10.5%) |
| Dec 2024 | $438.06M(-7.2%) | $119.47M(+12.6%) |
| Sep 2024 | - | $106.06M(-2.5%) |
| Jun 2024 | - | $108.76M(+4.8%) |
| Mar 2024 | - | $103.76M(-6.9%) |
| Dec 2023 | $472.00M(+16.8%) | $111.48M(-4.6%) |
| Sep 2023 | - | $116.92M(-9.7%) |
| Jun 2023 | - | $129.54M(+17.9%) |
| Mar 2023 | - | $109.89M(+3.8%) |
| Dec 2022 | $404.13M(+21.1%) | $105.87M(+2.4%) |
| Sep 2022 | - | $103.41M(-1.1%) |
| Jun 2022 | - | $104.55M(+8.6%) |
| Mar 2022 | - | $96.31M(-0.9%) |
| Dec 2021 | $333.59M(+36.1%) | $97.18M(+26.9%) |
| Sep 2021 | - | $76.60M(-4.4%) |
| Jun 2021 | - | $80.15M(+1.8%) |
| Mar 2021 | - | $78.77M(+15.6%) |
| Dec 2020 | $245.13M(-1.8%) | $68.17M(+17.0%) |
| Sep 2020 | - | $58.28M(-3.6%) |
| Jun 2020 | - | $60.48M(+4.8%) |
| Mar 2020 | - | $57.73M(-1.5%) |
| Dec 2019 | $249.51M(+19.2%) | $58.61M(+1.1%) |
| Sep 2019 | - | $57.99M(-19.5%) |
| Jun 2019 | - | $72.06M(+17.4%) |
| Mar 2019 | - | $61.38M(+15.3%) |
| Dec 2018 | $209.38M(+29.5%) | $53.24M(-1.3%) |
| Sep 2018 | - | $53.93M(-2.1%) |
| Jun 2018 | - | $55.06M(+17.8%) |
| Mar 2018 | - | $46.76M(+12.0%) |
| Dec 2017 | $161.70M | $41.76M(+4.8%) |
| Sep 2017 | - | $39.85M(-9.4%) |
| Jun 2017 | - | $44.00M(+10.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $39.69M(-6.7%) |
| Dec 2016 | $147.52M(+26.5%) | $42.52M(+11.4%) |
| Sep 2016 | - | $38.18M(+3.4%) |
| Jun 2016 | - | $36.91M(+23.4%) |
| Mar 2016 | - | $29.91M(-12.9%) |
| Dec 2015 | $116.58M(+14.2%) | $34.32M(+5.6%) |
| Sep 2015 | - | $32.50M(+22.9%) |
| Jun 2015 | - | $26.45M(+12.9%) |
| Mar 2015 | - | $23.42M(-26.2%) |
| Dec 2014 | $102.04M(+315.5%) | $31.76M(+6.8%) |
| Sep 2014 | - | $29.74M(+21.0%) |
| Jun 2014 | - | $24.58M(+48.5%) |
| Mar 2014 | - | $16.55M(+40.1%) |
| Dec 2013 | $24.56M(-18.5%) | $11.82M(+173.4%) |
| Sep 2013 | - | $4.32M(+90.4%) |
| Jun 2013 | - | $2.27M(+3.3%) |
| Mar 2013 | - | $2.20M(-92.7%) |
| Dec 2012 | $30.13M(>+9900.0%) | $30.12M(>+9900.0%) |
| Nov 2011 | - | $0.00(0.0%) |
| Aug 2011 | - | $0.00(0.0%) |
| May 2011 | - | $0.00(-100.0%) |
| Feb 2011 | $700.00(-53.3%) | $600.00(+500.0%) |
| Nov 2010 | - | $100.00(>+9900.0%) |
| Aug 2010 | - | $0.00(0.0%) |
| May 2010 | - | $0.00(-100.0%) |
| Feb 2010 | $1500.00(+7.1%) | $400.00(>+9900.0%) |
| Nov 2009 | - | $0.00(-100.0%) |
| Aug 2009 | - | $100.00(-90.0%) |
| May 2009 | - | $1000.00(-600.0%) |
| Feb 2009 | $1400.00(-97.3%) | -$200.00(-115.4%) |
| Nov 2008 | - | $1300.00(>+9900.0%) |
| Aug 2008 | - | $0.00(-100.0%) |
| May 2008 | - | $400.00 |
| Feb 2008 | $52.00K | - |
FAQ
- What is Travere Therapeutics, Inc. annual total operating expenses?
- What is the all time high annual operating expenses for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. annual operating expenses year-on-year change?
- What is Travere Therapeutics, Inc. quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. quarterly operating expenses year-on-year change?
What is Travere Therapeutics, Inc. annual total operating expenses?
The current annual operating expenses of TVTX is $438.06M
What is the all time high annual operating expenses for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high annual total operating expenses is $472.00M
What is Travere Therapeutics, Inc. annual operating expenses year-on-year change?
Over the past year, TVTX annual total operating expenses has changed by -$33.94M (-7.19%)
What is Travere Therapeutics, Inc. quarterly total operating expenses?
The current quarterly operating expenses of TVTX is $111.56M
What is the all time high quarterly operating expenses for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high quarterly total operating expenses is $129.54M
What is Travere Therapeutics, Inc. quarterly operating expenses year-on-year change?
Over the past year, TVTX quarterly total operating expenses has changed by +$2.80M (+2.58%)